318
Views
8
CrossRef citations to date
0
Altmetric
Articles

Voxel-based statistical analysis of brain metabolism in patients with growth hormone deficiency after traumatic brain injury

, , , , , & show all
Pages 407-413 | Received 19 May 2015, Accepted 01 Dec 2015, Published online: 24 Feb 2016

References

  • Agha A, Thompson CJ. Anterior pituitary dysfunction following traumatic brain injury (TBI). Clinical Endocrinology (Oxford) 2006;64:481–488.
  • Elovic EP. Anterior pituitary dysfunction after traumatic brain injury, Part I. Journal of Head Trauma Rehabilitation 2003;18:541–543.
  • Elovic EP, Glenn MB. Anterior pituitary dysfunction after traumatic brain injury, part II. Journal of Head Trauma Rehabilitation 2004;19:184–187.
  • Gunn IR, Beastall GH, Matthews DM, Bath JC. Post-traumatic hypothalamic-pituitary dysfunction presenting with biochemical features of primary hypothyroidism. Annals of Clinical Biochemistry 1991;28:327–330.
  • Lieberman SA, Oberoi AL, Gilkison CR, Masel BE, Urban RJ. Prevalence of neuroendocrine dysfunction in patients recovering from traumatic brain injury. Journal of Clinical Endocrinology & Metabolism 2001;86:2752–2756.
  • Park KD, Kim DY, Lee JK, Nam HS, Park YG. Anterior pituitary dysfunction in moderate-to-severe chronic traumatic brain injury patients and the influence on functional outcome. Brain Injury 2010;24:1330–1335.
  • Kelly DF, Gonzalo IT, Cohan P, Berman N, Swerdloff R, Wang C. Hypopituitarism following traumatic brain injury and aneurysmal subarachnoid hemorrhage: a preliminary report. Journal of Neurosurgery 2000;93:743–752.
  • Burman P, Hetta J, Wide L, MÃnsson JE, Ekman R, Karlsson FA. Growth hormone treatment affects brain neurotransmitters and thyroxine. Clinical Endocrinology 1996;44:319–324.
  • Nyberg F. Growth hormone in the brain: characteristics of specific brain targets for the hormone and their functional significance. Frontiers in Neuroendocrinology 2000;21:330–348.
  • Adem A, Jossan SS, d’Argy R, Gillberg PG, Nordberg A, Winblad B, Sara V. Insulin-like growth factor I (IGF-I) receptors in the human brain: quantitative autoradiographic localization. Brain Research 1989;503:299–303.
  • Lai Z, Roos P, Zhai O, Olsson Y, FhÃlenhag K, Larsson C, Nyberg F. Age-related reduction of human growth hormone-binding sites in the human brain. Brain Research 1993;621:260–266.
  • Carson MJ, Behringer RR, Brinster RL, Mc- Morris FA. Insulin-like growth factor I in- creases brain growth and central nervous sys- tem myelination in transgenic mice. Neuron 1993;10:729–740.
  • Dentremont KD, Ye P, D’Ercole AJ, O’Kusky JR. Increased insulin-like growth factor-I (IGF-I) expression during early postnatal development differentially increases neuron number and growth in medullary nuclei of the mouse. Brain Research 1999;114:135–141.
  • Araujo DM, Lapchak PA, Collier B, Chabot JG, Quirion R. Insulin-like growth factor-1 (somatomedin-C) receptors in the rat brain: distribution and interaction with the hippo- campal cholinergic system. Brain Research 1989;484:130–138.
  • Lynch CD, Lyons D, Khan A, Bennett SA, Sonntag WE. Insulin-like growth factor-1 se- lectively increases glucose utilization in brains of aged animals. Endocrinology 2001;142:506–569.
  • Sonntag WE, Bennett SA, Khan AS, Thornton PL, Xu X, Ingram RL, Brunso-Bechtold JK. Age and insulin-like growth factor-1 modulate N-methyl-D-aspartate receptor subtype expression in rats. Brain Research Bulletin 2000;51:331–338.
  • Pathipati P, Gorba T, Scheepens A, Goffin V, Sun Y, Fraser M. Growth hormone and prolactin regulate human neural stem cell regenerative activity. Neuroscience 2011;190:409–427.
  • Rollero A, Murialdo G, Fonzi S, Garrone S, Gianelli MV, Gazzerro E, Barreca A, Polleri A. Relationship between cognitive function, growth hormone and insulin-like growth factor I plasma levels in aged subjects. Neuropsychobiology 1998;38:73–79.
  • Kalmijn S, Janssen JA, Pols HA, Lamberts SW, Breteler MM. A prospective study on circulating insulin-like growth factor I (IGF-I), IGF-binding proteins, and cognitive function in the elderly. The Journal of Clinical Endocrinology and Metabolism 2000;85:4551–4555.
  • Van Dam PS, Aleman A. Insulin-like growth factor-I, cognition and brain aging. European Journal of Pharmacology 2004;490:87–95.
  • Maruff P, Falleti M. Cognitive function in growth hormone deficiency. Hormone Research 2005;64(Suppl 3):100–108.
  • Burman P, Deijen JB. Quality of life and cognitive function in patients. Psychotherapy & Psychosomatics 1998;67:154–167.
  • Siemensma EP, Tummers-de Lind van Wijngaarden RF, Festen DA, Troeman ZC, van Alfen-van der Velden AA, Otten BJ, Rotteveel J, Odink RJ, Bindels-de Heus GC, van Leeuwen M, et al. Beneficial effects of growth hormone treatment on cognition in children with Prader-Willi syndrome: a randomized controlled trial and longitudinal study. Journal of Clinical Endocrinology & Metabolism 2012;97:2307–2314.
  • Moreau OK, Cortet-Rudelli C, Yollin E, Merlen E, Daveluy W, Rousseaux M. Growth hormone replacement therapy in patients with traumatic brain injury. Journal of Neurotrauma 2013;30:998–1006.
  • Molitch ME, Clemmons DR, Malozowski S, Merriam GR, Vance ML; Endocrine Society. Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology & Metabolism 2011;96:1587–1609.
  • Varrone A, Asenbaum S, Vander Borght T, Booij J, Nobili F, Någren K, Darcourt J, Kapucu OL, Tatsch K, Bartenstein P, Van Laere K; European Association of Nuclear Medicine Neuroimaging Committee. EANM procedure guidelines for PET brain imaging using [18F] FDG, version 2. European Journal of Nuclear Medicine & Molecuar Imaging 2009;36:2103–2110.
  • Tzourio-Mazoyer N., Landeau B., Papathanassiou D., Crivello F., Etard O., Delcroix N., Mazoyer B., Joliot M. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. NeuroImage 2002;15:273–289.
  • Lobie PE, Garcia-Aragon J, Lincoln DT, Barnard R, Wilcox JN, Waters MJ. Localization and ontogeny of growth hormone receptor gene expression in the central nervous system. Developmental Brain Research 1993;74:225–233.
  • Aberg ND, Brywe KG, Isgaard J. Aspects of growth hormone and insulin-like growth factor-I related to neuroprotection, regeneration, and functional plasticity in the adult brain. Scientific World Journal 2006;18:53–80.
  • Schneider HJ, Pagotto U, Stalla GK. Central effects of the somatotropic system. European Journal of Endocrinology 2003;149:377–392.
  • Le-Greves M, Zhou Q, Berg M, Le-Greves P, Fholenhag K, Meyerson B, Nyberg F. Growth hormone replacement in hypophysectomized rats affects spatial performance and hippocampal levels of NMDA receptor subunit and PSD-95 gene transcript levels. Experimental Brain Research 2006;173:267–273.
  • Mahmoud GS, Grover LM. Growth hormone enhances excitatory synaptic transmission in area CA1 of rat hippocampus. Journal of Neurophysiology 2006;95:2962–2974.
  • Lichtenwalner RJ, Forbes ME, Sonntag WE, Riddle DR. Adult-onset deficiency in growth hormone and insulin-like growth factor-I decreases survival of dentate granule neurons: insights into the regulation of adult hippocampal neurogenesis. Journal of Neuroscience Research 2006;83:199–210.
  • Johansson, JO, Larson G, Andersson M, Elmgren A, Hynsjö L, Lindahl A, Lundberg PA, Isaksson OG, Lindstedt S, Bengtsson BA. Treatment of growth hormone-deficient adults with recombinant human growth hormone increases the concentration of growth hormone in the cerebrospinal fluid and affects neurotransmitters. Neuroendocrinology 1995;61:57–66.
  • Stern WC, Miller M, Jalowiec JE, Forbes WB, Morgane PJ. Effects of growth hormone on brain biogenic amine levels. Pharmacology Biochemistry & Behavior 1975;3:1115–1118.
  • Nilsson-Håkansson L, Civalero I, Zhang X, Carlsson-Skwirut C, Sara VR, Nordberg A. Effects of IGF-1, truncated IGF-1 and the tripeptide Gly-Pro-Glu on acetylcholine release from parietal cortex of rat brain. Neuroreport 1993;4:1111–1114.
  • Gillespie CM, Merkel AL, Martin AA. Effects of insulin-like growth factor-I and LR3IGF-I on regional blood flow in normal rats. Journal of Endocrinology 1997;155:351–358.
  • Sonntag WE, Lynch CD, Cooney PT, Hutchins PM. Decreases in cerebral microvasculature with age are associated with the decline in growth hormone and insulin-like growth factor 1. Endocrinology 1997;138:3515–3520.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.